PI
VERV

PEAK6 Investments’s Verve Therapeutics VERV Stock Holding History

PEAK6 Investments’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$121K Buy
+25,000
New +$145K ﹤0.01% 2935
2024
Q2 		– Sell
-20,000
Closed -$266K – 4388
2024
Q1 		$266K Buy
+20,000
New +$265K ﹤0.01% 2880
2023
Q4 		– Sell
-100
Closed -$1.33K – 4878
2023
Q3 		$1.33K Buy
+100
New +$1.61K ﹤0.01% 3917
2022
Q4 		– Sell
-5,600
Closed -$192K – 5260
2022
Q3 		$192K Buy
+5,600
New +$179K ﹤0.01% 3688

Other funds holding VERV

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

PEAK6 Investments's VERV Position: Q4 2023 in Review

PEAK6 Investments sold out of Verve Therapeutics (VERV) in Q4 2023, closing a stake of 18,000 shares — an estimated $239K sold.

PEAK6 Investments first reported a position in VERV in Q3 2023 and held it in 1 quarter. The position peaked at $239K in Q3 2023. 157 funds tracked by Wall St. Rank hold VERV as of Q4 2023.

  • PEAK6 Investments reported no remaining Verve Therapeutics position as of Q4 2023 after selling out during the quarter.
  • PEAK6 Investments sold 18,000 Verve Therapeutics shares in Q4 2023, an estimated $239K.
  • PEAK6 Investments first reported a position in Verve Therapeutics in Q3 2023 and held it in 1 quarter.
  • PEAK6 Investments's Verve Therapeutics position peaked at $239K in Q3 2023.
  • 157 funds tracked by Wall St. Rank held Verve Therapeutics as of Q4 2023.

Based on PEAK6 Investments's 13F filing for Q4 2023, filed 13 Feb 2024.